# Clinical Evaluation for Batch Consistency of Ad5-nCoV in Chinese Healthy Adults

> **NCT05313646** · PHASE4 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 1050 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** batch 1 of Ad5-nCoV
- **BIOLOGICAL:** batch 2 of Ad5-nCoV
- **BIOLOGICAL:** batch 3 of Ad5-nCoV

## Key facts

- **NCT ID:** NCT05313646
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-08
- **Primary completion:** 2021-04-08
- **Final completion:** 2021-09-08
- **Target enrollment:** 1050 (ACTUAL)
- **Last updated:** 2022-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05313646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05313646, "Clinical Evaluation for Batch Consistency of Ad5-nCoV in Chinese Healthy Adults". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05313646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*